Photosensitizer-thioglycosides enhance photodynamic therapy by augmenting cellular uptake

Shuen-Shiuan Wang,Shuai Shao,Arun Singh,Ryoma Hombu,Jonathan F. Lovell,Khushi L. Matta,Sriram Neelamegham
DOI: https://doi.org/10.1016/j.carres.2024.109119
IF: 2.975
2024-04-20
Carbohydrate Research
Abstract:Photodynamic therapy (PDT) uses photosensitizing agents along with light to ablate tissue, including cancers. Such light-driven localized delivery of free-radical oxygen to kill target tissue depends on photosensitizer cell penetration efficacy. While the attachment of monosaccharides and disaccharides to photosensitizers has been shown to potentially provide improved photosensitizer delivery, the range of glycan entities tested thus far is limited. We sought to expand such knowledge by coupling N-acetylglucosamine (GlcNAc) to pyropheophorbides as thioglycosides, and then testing photosensitizer efficacy. To this end, GlcNAc was conjugated to both pyropheophorbide-a and methyl pyropheophorbide-a. Among the entities tested, the conjugation of N-acetylglucosamine to methyl pyropheophorbide-a ('PSe') as thioglycoside enhanced cell uptake both in the presence and absence of human serum proteins, relative to other compounds tested. The enhanced PSe penetrance into cells resulted in higher cell death upon illumination with 665 nm light. While acting as a potent photosensitizer, PSe did not affect cellular carbohydrate profiles. Overall, the study presents a new pyropheophorbide glycoconjugate with strong in vitro PDT efficacy.
biochemistry & molecular biology,chemistry, organic, applied
What problem does this paper attempt to address?